RFA: Translational Strategies to Define & Monitor Vascularization for Islet Therapies
Funds translational methods to define, monitor, and improve vascularization in islet-based diabetes therapies.
Breakthrough T1D — the former JDRF, rebranded in June 2024 — issued this FY26 RFA on "Translational Strategies to Define and Monitor Vascularization for Islet Therapies" as part of its ongoing investment in the scientific infrastructure required for successful beta cell replacement. Vascularization — the integration of transplanted islets into the host vasculature — is a key determinant of graft s…
Translational research defining and monitoring vascularization as a biological determinant of outcomes in islet cell transplantation and replacement therapies for type 1 diabetes.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
Write proposalGrant Letter of Intent: How to Write an LOI or Letter of Inquiry
Learn what a grant letter of intent is, when funders ask for LOIs or letters of inquiry, what to include, what to avoid, and how funder rules differ.
More from Breakthrough T1D
All grants from this funder →Strategic Research Agreement — Round 1
Breakthrough T1D · United States
Funds investigator-led type 1 diabetes research partnerships across preclinical discovery, treatment, and translational priorities.
Strategic Research Agreement — Round 2
Breakthrough T1D · United States
Funds investigator-initiated type 1 diabetes projects spanning early detection, prevention, and advanced therapeutic development pipelines.
Advanced Postdoctoral Fellowship
Breakthrough T1D · United States
Funds advanced postdoctoral researchers with substantial support to strengthen independent study in type 1 diabetes science.
Career Development Award
Breakthrough T1D · United States
Supports early-career faculty establishing independent type one diabetes research programs.
Kellogg Family Early-Career Patient-Oriented Diabetes Research Award
Breakthrough T1D · United States
Supports early-career investigators in patient-oriented type 1 diabetes projects that connect translational goals with clinical outcomes.
Postdoctoral Fellowship
Breakthrough T1D · United States
Supports early-career postdoctoral researchers advancing type one diabetes research globally.
Similar grants
Browse the directory →
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy
🇺🇸NIH · United States
Funds work combining imaging with liquid biopsy during cancer treatment, to see sooner whether it is working or resistance is emerging.
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment
NIH · United States
Funds academic-industry partnerships that turn a lab discovery into a working diagnostic or treatment tool, without a clinical trial attached.
NIDCD Research Grants for Translating Basic Research into Clinical Practice
NIH · United States
Funds translational research turning basic findings into clinical tools for communication disorders, with practical clinical impact required.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds the development and hard technical validation that turns a working cancer research technology into one other laboratories will actually adopt.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds further development and rigorous technical validation of a cancer research technology that has already cleared basic feasibility.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
NIH · United States
Funds a Phase 0, I or II cancer trial that the investigator designed, inside one of six named National Cancer Institute programme areas.